Synthetic DNA Stocks Hit 52-Week High... Market Cap Increased by 770 Billion in One Day

Twist Bioscience Corporation (NASDAQ: TWST) closed at $57.41, up 13.95%, driving its market capitalization to roughly $3.52 billion (about ₩4.7 trillion).

In a single day, its market cap increased by approximately $570 million (around ₩770 billion), and trading volume swelled to over 2.24 million shares—significantly above its average.

During intraday trading, the stock hit a 52-week high of $57.90, bolstered by the company’s recent 2026 fiscal first-quarter results. Twist Bioscience raised its full-year revenue guidance and set a target to achieve adjusted EBITDA breakeven by year-end, fueling investor optimism. (Source: investing.com)

However, on April 9, CFO Adam Laponis disclosed an insider sale of 2,597 shares at an average price of $49.89 per share—totaling about $129,000 (roughly ₩170 million). (Source: ms.investing.com)

Headquartered in South San Francisco, Twist Bioscience is a synthetic biology company that uses a semiconductor-based platform to produce synthetic DNA and DNA-based products for the pharmaceutical, biotech, industrial, and data-storage sectors. (Source: en.wikipedia.org)

Founder and CEO Emily LeProust has driven the company’s growth through its DNA synthesis technology and, more recently, has expanded into antibody-drug discovery services via partnerships such as licensing a bispecific antibody platform. (Source: en.wikipedia.org)